Gut microbiota regulation of T lymphocyte subsets during systemic lupus erythematosus.
Gut microbiota
Systemic lupus erythematosus
T lymphocyte subsets
Journal
BMC immunology
ISSN: 1471-2172
Titre abrégé: BMC Immunol
Pays: England
ID NLM: 100966980
Informations de publication
Date de publication:
08 Jul 2024
08 Jul 2024
Historique:
received:
26
02
2024
accepted:
17
06
2024
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
7
7
2024
Statut:
epublish
Résumé
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by disturbance of pro-inflammatory and anti-inflammatory lymphocytes. Growing evidence shown that gut microbiota participated in the occurrence and development of SLE by affecting the differentiation and function of intestinal immune cells. The purpose of this study was to investigate the changes of gut microbiota in SLE and judge its associations with peripheral T lymphocytes. A total of 19 SLE patients and 16 HCs were enrolled in this study. Flow cytometry was used to detect the number of peripheral T lymphocyte subsets, and 16 s rRNA was used to detect the relative abundance of gut microbiota. Analyzed the correlation between gut microbiota with SLEDAI, ESR, ds-DNA and complement. SPSS26.0 software was used to analyze the experimental data. Mann-Whitney U test was applied to compare T lymphocyte subsets. Spearman analysis was used for calculating correlation. Compared with HCs, the proportions of Tregs (P = 0.001), Tfh cells (P = 0.018) and Naïve CD4 + T cells (P = 0.004) significantly decreased in SLE patients, and proportions of Th17 cells (P = 0.020) and γδT cells (P = 0.018) increased in SLE. The diversity of SLE patients were significantly decreased. Addition, there were 11 species of flora were discovered to be distinctly different in SLE group (P < 0.05). In the correlation analysis of SLE, Tregs were positively correlated with Ruminococcus2 (P = 0.042), Th17 cells were positively correlated with Megamonas (P = 0.009), γδT cells were positively correlated with Megamonas (P = 0.003) and Streptococcus (P = 0.004), Tfh cells were positively correlated with Bacteroides (P = 0.040), and Th1 cells were negatively correlated with Bifidobacterium (P = 0.005). As for clinical indicators, the level of Tregs was negatively correlated with ESR (P = 0.031), but not with C3 and C4, and the remaining cells were not significantly correlated with ESR, C3 and C4. Gut microbiota and T lymphocyte subsets of SLE changed and related to each other, which may break the immune balance and affect the occurrence and development of SLE. Therefore, it is necessary to pay attention to the changes of gut microbiota and provide new ideas for the treatment of SLE.
Sections du résumé
BACKGROUND
BACKGROUND
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by disturbance of pro-inflammatory and anti-inflammatory lymphocytes. Growing evidence shown that gut microbiota participated in the occurrence and development of SLE by affecting the differentiation and function of intestinal immune cells. The purpose of this study was to investigate the changes of gut microbiota in SLE and judge its associations with peripheral T lymphocytes.
METHODS
METHODS
A total of 19 SLE patients and 16 HCs were enrolled in this study. Flow cytometry was used to detect the number of peripheral T lymphocyte subsets, and 16 s rRNA was used to detect the relative abundance of gut microbiota. Analyzed the correlation between gut microbiota with SLEDAI, ESR, ds-DNA and complement. SPSS26.0 software was used to analyze the experimental data. Mann-Whitney U test was applied to compare T lymphocyte subsets. Spearman analysis was used for calculating correlation.
RESULTS
RESULTS
Compared with HCs, the proportions of Tregs (P = 0.001), Tfh cells (P = 0.018) and Naïve CD4 + T cells (P = 0.004) significantly decreased in SLE patients, and proportions of Th17 cells (P = 0.020) and γδT cells (P = 0.018) increased in SLE. The diversity of SLE patients were significantly decreased. Addition, there were 11 species of flora were discovered to be distinctly different in SLE group (P < 0.05). In the correlation analysis of SLE, Tregs were positively correlated with Ruminococcus2 (P = 0.042), Th17 cells were positively correlated with Megamonas (P = 0.009), γδT cells were positively correlated with Megamonas (P = 0.003) and Streptococcus (P = 0.004), Tfh cells were positively correlated with Bacteroides (P = 0.040), and Th1 cells were negatively correlated with Bifidobacterium (P = 0.005). As for clinical indicators, the level of Tregs was negatively correlated with ESR (P = 0.031), but not with C3 and C4, and the remaining cells were not significantly correlated with ESR, C3 and C4.
CONCLUSION
CONCLUSIONS
Gut microbiota and T lymphocyte subsets of SLE changed and related to each other, which may break the immune balance and affect the occurrence and development of SLE. Therefore, it is necessary to pay attention to the changes of gut microbiota and provide new ideas for the treatment of SLE.
Identifiants
pubmed: 38972998
doi: 10.1186/s12865-024-00632-0
pii: 10.1186/s12865-024-00632-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
41Subventions
Organisme : Natural Science Research Project of Shanxi Province
ID : 20210302123275
Informations de copyright
© 2024. The Author(s).
Références
Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):ITC81–96.
doi: 10.7326/AITC202006020
pubmed: 32479157
Herrada AA, Escobedo N, Iruretagoyena M, et al. Innate immune cells’ contribution to systemic lupus erythematosus. Front Immunol. 2019;10:772.
doi: 10.3389/fimmu.2019.00772
pubmed: 31037070
pmcid: 6476281
Al-Rayes H, Al-Swailem R, Arfin M, Sobki S, Rizvi S, Tariq M. Systemic lupus erythematosus and infections: a retrospective study in Saudis. Lupus. 2007;16(9):755–63.
doi: 10.1177/0961203307079943
pubmed: 17728372
Takeshima Y, Iwasaki Y, Fujio K, Yamamoto K. Metabolism as a key regulator in the pathogenesis of systemic lupus erythematosus. Semin Arthritis Rheum. 2019;48(6):1142–5.
doi: 10.1016/j.semarthrit.2019.04.006
pubmed: 31056210
Sharabi A, Tsokos GC. T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol. 2020;16(2):100–12.
doi: 10.1038/s41584-019-0356-x
pubmed: 31949287
Silverman GJ, Azzouz DF, Alekseyenko AV. Systemic Lupus Erythematosus and dysbiosis in the microbiome: cause or effect or both? Curr Opin Immunol. 2019;61:80–5.
doi: 10.1016/j.coi.2019.08.007
pubmed: 31590039
pmcid: 6901743
Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol. 2007;157(3):540–6.
doi: 10.1111/j.1365-2133.2007.08056.x
pubmed: 17596147
Kosiewicz MM, Dryden GW, Chhabra A, Alard P. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett. 2014;588(22):4195–206.
doi: 10.1016/j.febslet.2014.03.019
pubmed: 24681103
Mu Q, Zhang H, Liao X, et al. Control of lupus nephritis by changes of gut microbiota. Microbiome. 2017;5(1):73.
doi: 10.1186/s40168-017-0300-8
pubmed: 28697806
pmcid: 5505136
Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–21.
doi: 10.1056/NEJMra1100359
pubmed: 22129255
Li H, Boulougoura A, Endo Y, Tsokos GC. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies. J Autoimmun. 2022;132:102870.
doi: 10.1016/j.jaut.2022.102870
pubmed: 35872102
Muhammad Yusoff F, Wong KK, Mohd RN. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus. Autoimmunity. 2020;53(1):8–20.
doi: 10.1080/08916934.2019.1693545
pubmed: 31771364
Craft JE. Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol. 2012;8(6):337–47.
doi: 10.1038/nrrheum.2012.58
pubmed: 22549246
pmcid: 3604997
Zhang F, Cheng T, Zhang SX. Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis. Arthritis Res Ther. 2023;25(1):187.
doi: 10.1186/s13075-023-03181-w
pubmed: 37784141
pmcid: 10544394
Jin X, Chen J, Wu J, et al. Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus. Front Immunol. 2022;13:928359.
doi: 10.3389/fimmu.2022.928359
pubmed: 36119056
pmcid: 9478104
Wu M, Yang J, Li X, Chen J. The Role of gammadelta T Cells in Systemic Lupus Erythematosus. J Immunol Res. 2016;2016:2932531.
doi: 10.1155/2016/2932531
pubmed: 26981547
pmcid: 4766344
Christovich A, Luo XM. Gut Microbiota, Leaky Gut, and Autoimmune Diseases. Front Immunol. 2022;13:946248.
doi: 10.3389/fimmu.2022.946248
pubmed: 35833129
pmcid: 9271567
Zhao T, Wei Y, Zhu Y, et al. Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities. Front Immunol. 2022;13:1007165.
doi: 10.3389/fimmu.2022.1007165
pubmed: 36159786
pmcid: 9499173
Talaat RM, Mohamed SF, Bassyouni IH, Raouf AA. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine. 2015;72(2):146–53.
doi: 10.1016/j.cyto.2014.12.027
pubmed: 25647269
Zhao C, Chu Y, Liang Z, et al. Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients. BMC Immunol. 2019;20(1):32.
doi: 10.1186/s12865-019-0305-0
pubmed: 31484501
pmcid: 6727508
Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021;12:578386.
doi: 10.3389/fimmu.2021.578386
pubmed: 33717063
pmcid: 7953067
Ma Y, Xu X, Li M, Cai J, Wei Q, Niu H. Gut microbiota promote the inflammatory response in the pathogenesis of systemic lupus erythematosus. Mol Med. 2019;25(1):35.
doi: 10.1186/s10020-019-0102-5
pubmed: 31370803
pmcid: 6676588
Luo XM, Edwards MR, Mu Q, et al. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol. 2018;84(4):e02288–17.
doi: 10.1128/AEM.02288-17
pubmed: 29196292
pmcid: 5795066
Balmant BD, Fonseca DC, Prudencio APA, et al. Megamonas funiformis, plasma zonulin, and sodium intake affect C3 complement levels in inactive systemic lupus erythematosus. Nutrients. 2023;15(8):1999.
doi: 10.3390/nu15081999
pubmed: 37111218
pmcid: 10144636
Liu F, Du J, Zhai Q, et al. The bladder microbiome, metabolome, cytokines, and phenotypes in patients with systemic lupus erythematosus. Microbiol Spectr. 2022;10(5):e0021222.
doi: 10.1128/spectrum.00212-22
pubmed: 35913213
Li Y, Li Z, Sun W, Wang M, Li M. Characteristics of gut microbiota in patients with primary Sjogren’s syndrome in Northern China. PLoS ONE. 2022;17(11):e0277270.
doi: 10.1371/journal.pone.0277270
pubmed: 36355832
pmcid: 9648750
Ling Z, Jin C, Xie T, Cheng Y, Li L, Wu N. Alterations in the fecal microbiota of patients with HIV-1 infection: an observational study in a Chinese population. Sci Rep. 2016;6:30673.
doi: 10.1038/srep30673
pubmed: 27477587
pmcid: 4967929
Wang T, Sternes PR, Guo XK, Zhao H, Xu C, Xu H. Autoimmune diseases exhibit shared alterations in the gut microbiota. Rheumatology (Oxford). 2024;63(3):856–65.
doi: 10.1093/rheumatology/kead364
pubmed: 37467058
Lopez P, de Paz B, Rodriguez-Carrio J, et al. Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients. Sci Rep. 2016;6:24072.
doi: 10.1038/srep24072
pubmed: 27044888
pmcid: 4820712
Li Y, Wang HF, Li X, et al. Disordered intestinal microbes are associated with the activity of Systemic Lupus Erythematosus. Clin Sci (Lond). 2019;133(7):821–38.
doi: 10.1042/CS20180841
pubmed: 30872359
Zhang Y, Liu Q, Yu Y, Wang M, Wen C, He Z. Early and short-term interventions in the gut microbiota affects lupus severity, progression, and treatment in MRL/lpr mice. Front Microbiol. 2020;11:628.
doi: 10.3389/fmicb.2020.00628
pubmed: 32346376
pmcid: 7171286